—
C+
C+ The full Closelook — membership. Open the C+ overview

Sartorius AG VZO O.N. (SRT.DE) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Sartorius AG VZO O.N.

SRT.DE in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Sartorius makes bioprocess equipment and laboratory instruments used to develop and manufacture biological drugs, filters, cell-culture media, weighing systems and lab software. It serves life-science researchers, biopharmaceutical manufacturers and cell-and-gene therapy developers. It is based in Göttingen, Germany.
Where it sits in the stack
Sartorius is not part of our AI build-out index; it sits in the HALO Growth 100, our growth index outside the megacaps, within the sleeve for surgical, medical-device and animal-health names. That sleeve groups regulated equipment makers whose customers are hospitals, labs and biomanufacturers rather than chipmakers or data centres.
Who it is priced against
Closelook's peer group places it with Intuitive Surgical, Stryker, DexCom, Insulet, IDEXX Laboratories, Globus Medical and Sonova, grouped as regulated compounders in surgery, devices and animal health; the market also compares it with Thermo Fisher Scientific.
Why Closelook tracks it
It holds a seat in the HALO Growth 100 and carries a Closelook score, with momentum the strongest module and valuation the weakest; the diary has not yet quoted it in an edition.
What the diary watches
Whether demand from biopharmaceutical manufacturing recovers after the post-pandemic destocking that has weighed on bioprocessing order books.

Sartorius AG VZO O.N. (SRT.DE) trades on the XETRA exchange in Germany, classified under Healthcare. Constituent of HALO Growth 100.

The Closelook company score reads 42/100 composite (momentum 67, quality 43, valuation 34) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for SRT.DE, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against HALO Growth 100 · Surgical, Med Devices & Animal Health · 7 names with week and year-to-date

Peer group

HALO Growth 100 · Surgical, Med Devices & Animal Health

Robotic surgery, continuous-glucose sensors, cochlear implants, animal-health platforms. Regulated moats, multi-decade compounders.

Compared against SRT.DE on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Versus its index HALO Growth 100 — the name, its sleeve and the index over day, week and month

Versus its index

The name against its Closelook index and its own sleeve — equal-weight, nightly closes.

HALO Growth 100 · as of 2026-09-17

DayWeekMonth3 months
SRT.DE+1.2%+7.2%+4.8%+11.3%
Surgical, Med Devices & Animal Health+0.1%+2.7%−8.2%—
HALO Growth 100+0.9%−0.7%−8.0%—

Against the index: 7.9 pts ahead on the week, 12.8 pts ahead on the month; against its Surgical, Med Devices & Animal Health sleeve 13.0 pts ahead on the month.

Returns from the index workers’ nightly closes; equal-weight sleeves. A relative reading from the research diary, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sector × region Health care in Europe: +1.1% week · −3.6% month · +0.3% quarter · −6.5% yearThe Sector Engine cell this name lives in, from EXV4.XETRA; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-16
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Sartorius AG VZO O.N. (SRT.DE)?

Sartorius AG VZO O.N. trades as SRT.DE on the XETRA exchange (Germany) and is classified under Healthcare in the Closelook research universe, as of the registry build of 2026-09-18.

Is SRT.DE in a Closelook index?

Yes — Sartorius AG VZO O.N. is a constituent of HALO Growth 100, as of 2026-09-18.

What is Sartorius AG VZO O.N.'s Closelook composite score?

42 out of 100, with momentum 67, quality 43 and valuation 34 sub-scores, as of 2026-09-18. Scores are Closelook's own research readings, not ratings or investment advice.

Where does SRT.DE trade against its moving averages?

Reclaimed its 50-day: Closed back above its 50-day line 3 sessions ago, with the 200-day still rising beneath it. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

How is SRT.DE doing against its Closelook index?

Over the past month Sartorius AG VZO O.N. is +4.8% against −8.0% for the HALO Growth 100 — 12.8 points ahead of its index, as of 2026-09-17. Its Surgical, Med Devices & Animal Health sleeve is −8.2% over the same month. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.

What does Sartorius AG VZO O.N. do?

Sartorius makes bioprocess equipment and laboratory instruments used to develop and manufacture biological drugs, filters, cell-culture media, weighing systems and lab software. It serves life-science researchers, biopharmaceutical manufacturers and cell-and-gene therapy developers. It is based in Göttingen, Germany. Closelook's peer group places it with Intuitive Surgical, Stryker, DexCom, Insulet, IDEXX Laboratories, Globus Medical and Sonova, grouped as regulated compounders in surgery, devices and animal health; the market also compares it with Thermo Fisher Scientific.

Where does Sartorius AG VZO O.N. sit in the AI build-out?

Sartorius is not part of our AI build-out index; it sits in the HALO Growth 100, our growth index outside the megacaps, within the sleeve for surgical, medical-device and animal-health names. That sleeve groups regulated equipment makers whose customers are hospitals, labs and biomanufacturers rather than chipmakers or data centres. It holds a seat in the HALO Growth 100 and carries a Closelook score, with momentum the strongest module and valuation the weakest; the diary has not yet quoted it in an edition.

What does this page show?

A live price chart with SMA overlays and drawing tools for SRT.DE, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe